The Department of Health will fully fund a roll out of anti-retroviral drug Pre-exposure prophylaxis, more commonly referred to as PrEP, in England, reports Buzzfeed.
The drug, if taken consistently by HIV-negative people, can help to dramatically reduce the risk of acquiring the virus. PrEP will become publicly available for those most at risk of catching HIV before the end of the year.